Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States
2020 ◽
Vol 126
(8)
◽
pp. 1736-1748
◽
Ang Li
◽
Josh J. Carlson
◽
Nicole M. Kuderer
◽
Jordan K. Schaefer
◽
Shan Li
◽
...
2019 ◽
Vol 180
◽
pp. 37-42
◽
Ang Li
◽
Poorni M. Manohar
◽
David A. Garcia
◽
Gary H. Lyman
◽
Lotte M. Steuten
R. Arjunji
◽
J. Zhou
◽
A. Patel
◽
M.L. Edwards
◽
M. Harvey
◽
...
Ash Bullement
◽
Emma S. Knowles
◽
Pronabesh DasMahapatra
◽
Talaha Ali
◽
Ron Preblick
2021 ◽
Vol 41
(5)
◽
pp. 1097-1104
Feng Wen
◽
Hanrui Zheng
◽
Pengfei Zhang
◽
Weiting Liao
◽
Kexun Zhou
◽
...
2015 ◽
Vol 10
(2)
◽
pp. e0116694
◽
Dahye L. Song
◽
Frederick L. Altice
◽
Michael M. Copenhaver
◽
Elisa F. Long
2017 ◽
Vol 28
(4)
◽
pp. 1578-1597
◽
Jinjing Wu
◽
Kelsey S. Dean
◽
Zohn Rosen
◽
Peter A. Muennig
Hanke Zheng
◽
Cynthia Gong
◽
Rachel Chapman
◽
Leah Yieh
◽
Philippe Friedlich
◽
...
2018 ◽
Vol 38
(5)
◽
pp. 520-530
◽
Patrick M. Zueger
◽
Varun M. Kumar
◽
Rachel L. Harrington
◽
Gianna C. Rigoni
◽
Alicia Atwood
◽
...